Summary Regulatory T (Treg) cells are critical in regulating the immune response. In vitro induced Treg (iTreg) cells have significant potential in clinical medicine. However, applying iTreg cells as therapeutics is complicated by the poor stability of human iTreg cells and their variable suppressive activity. Therefore, it is important to understand the molecular mechanisms of human iTreg cell specification. We identified hypermethylated in cancer 1 (HIC1) as a transcription factor upregulated early during the differentiation of human iTreg cells. Although FOXP3 expression was unaffected, HIC1 deficiency led to a considerable loss of suppression by iTreg cells with a concomitant increase in the expression of effector T cell associated genes. SNPs linked to several immune-mediated disorders were enriched around HIC1 binding sites, and in vitro binding assays indicated that these SNPs may alter the binding of HIC1. Our results suggest that HIC1 is an important contributor to iTreg cell development and function.
Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells
Ullah Ubaid Ullah,Syed Bilal Ahmad Andrabi,S. Tripathi,Obaiah Dirasantha,Kartiek Kanduri,Kartiek Kanduri,Sini Rautio,C. Gross,S. Lehtimäki,K. Bala,J. Tuomisto,Urvashi Bhatia,D. Chakroborty,L. Elo,H. Lähdesmäki,H. Lähdesmäki,H. Wiendl,O. Rasool,R. Lahesmaa
Published 2018 in Cell Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Cell Reports
- Publication date
2018-02-20
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-76 of 76 references · Page 1 of 1
CITED BY
Showing 1-63 of 63 citing papers · Page 1 of 1